Corient Capital Partners’s Astria Therapeutics ATXS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9,222	Closed	-$117K	–	696
2021 Q2	$117K	Sell	9,222 -8,032	-47%	-$102K	0.01%	659
2021 Q1	$299K	Buy	+17,254	New	+$299K	0.03%	448